CT scans can effectively rule out esophageal perforation in patients with spontaneous pneumomediastinum. Of 82 patients, only 14 (17.1%) had a confirmed perforation, all showing pleural or mediastinal fluid. Pleural/mediastinal fluid had 100% sensitivity and negative predictive value for perforation. Patients without pleural or mediastinal fluid can avoid unnecessary transfers and further testing. Perforation patients […]
Category: General Surgery
Monitoring MPD Growth Crucial in IPMN Management
Dynamic changes in main pancreatic duct (MPD) diameter are key in predicting malignancy risk for patients with MPD-involved IPMN. In a study of 168 patients, 17.8% developed malignancy over a median of 4 years, with an annual incidence of 4.5%. An MPD growth rate of ≥ 2 mm/year emerged as the strongest predictor, with a […]
Roux-en-Y Bypass Outperforming Sleeve Gastrectomy for Diabetes Remission
Roux-en-Y gastric bypass offers better outcomes for type 2 diabetes remission than sleeve gastrectomy in obese patients. Patients receiving Roux-en-Y showed higher remission rates for diabetes at 1 and 3 years, with significant differences from sleeve gastrectomy. At 1 and 3 years, HbA1c levels were lower in the Roux-en-Y group, indicating better glycemic control. Prioritize […]
ERAS Cuts Hospital Stay for Peptic Perforation Patients
Enhanced recovery after surgery (ERAS) significantly benefits patients with peptic perforation, reducing hospital stays and accelerating recovery. Median hospital stay was 3 days in the ERAS group versus 5 days in conventional care. Patients walked within 21 hours post-surgery, compared to 48 hours in the conventional group. Implementing ERAS can lead to quicker recoveries and […]
Cost-Effective Surgery for Complicated Diverticulitis
Early non-emergent colectomy is more cost-effective and beneficial for patients with complicated diverticulitis and abscess. Early operation results in $8,852 lower costs per patient and an incremental increase of 0.57 quality-adjusted life years (QALYs). This strategy is cost-effective 96% of the time when compared to interval operation. Surgeons should prioritize early intervention but consider patient […]
New diabetes risk model improves post-pancreatectomy care
Surgeons can leverage a simple scoring system to predict new-onset diabetes after distal pancreatectomy, enhancing patient management. 26.9% of non-diabetic patients developed diabetes within 10 months post-surgery. Five key predictors include prediabetes, age ≥65, BMI ≥25, neck/proximal tumor, and concomitant splenectomy. The scoring system stratifies patients into risk categories with 5-year cumulative incidences of 4.4% […]
Piperacillin-tazobactam outperforms cefoxitin for pancreatoduodenectomy
Switching to piperacillin-tazobactam for prophylaxis significantly lowers surgical site infections and pancreatic fistula rates in open pancreatoduodenectomy. Patients on piperacillin-tazobactam had 30% fewer surgical site infections and pancreatic fistulas compared to those on cefoxitin. The switch is backed by data from over 4,000 patients, with a clear trend toward piperacillin-tazobactam usage increasing. Consider adopting piperacillin-tazobactam […]
Reassessing Surgery for Mucinous Cystic Neoplasms
Surgical interventions for mucinous cystic neoplasms (MCN) should be more selective based on updated risk factors. The pooled rate of high-grade dysplasia (HGD) or invasive carcinoma (IC) in resected MCNs is just 17%. Cyst size is crucial: a threshold of 65 mm best differentiates high-risk from low-risk lesions. Key risk factors linked to HGD/IC include […]
Minimally Invasive CME Outperform Conventional Hemicolectomy
Minimally invasive complete mesocolic excision (CME) shows improved outcomes in right-sided colon cancer surgery. 6.09 more lymph nodes retrieved with CME (p < 0.001) Anastomotic leakage is lower with CME (0.87% vs. 1.86%, RR: 0.49) 3-year overall survival improves with CME (85.4% vs. 82.2%) CME offers better oncological results and safety in short-term outcomes, suggesting a shift […]
Audit Reveals Improved Outcomes in Acute GI Bleeding
A recent UK audit on acute upper gastrointestinal bleeding shows improved patient outcomes despite higher comorbidities and inappropriate transfusion practices. Comorbidities rose from 50% to 67%, with 15% of patients having cirrhosis. Transfusion rates increased to 50%, and 24% of early transfusions were deemed inappropriate, linked to higher adjusted mortality at hemoglobin thresholds above 80 […]